Handelsbanken Fonder’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$732K Buy
+128,900
New +$630K ﹤0.01% 1264
2022
Q4
Sell
-41,400
Closed -$93K 1587
2022
Q3
$93K Hold
41,400
﹤0.01% 1528
2022
Q2
$134K Sell
41,400
-2,400
-5% -$10.5K ﹤0.01% 1554
2022
Q1
$230K Hold
43,800
﹤0.01% 1605
2021
Q4
$372K Buy
+43,800
New +$403K ﹤0.01% 1533

Other funds holding NUVB

Handelsbanken Fonder's NUVB Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Nuvation Bio (NUVB) in Q2 2026: 128,900 shares worth $732K. The stake represents ﹤0.01% of the portfolio and ranks #1264 among its holdings. This is a return to the name: Handelsbanken Fonder previously reported a position in NUVB as recently as Q3 2022.

Handelsbanken Fonder first reported a position in NUVB in Q4 2021 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Handelsbanken Fonder held 128,900 shares of Nuvation Bio worth $732K as of Q2 2026.
  • Nuvation Bio was a new Handelsbanken Fonder position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1264 holding.
  • Handelsbanken Fonder first reported a position in Nuvation Bio in Q4 2021 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.